Friday, July 10, 2026

pharma · Breast Neoplasms · Radiation Injuries

Sun Yat-sen Memorial

Sun Yat-Sen Memorial is a pharma organization headquartered in CN. Primary therapeutic focus areas include Breast Neoplasms, Radiation Injuries, Breast Cancer, Platinum-resistant Recurrent Clear Cell Ovarian Cancer, Brea

Guangzhou, CN HQ
32 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Guangzhou, CN
Employees
32
Programs
7
Drugs
16
Patents
0
Clinical program

Paclitaxel oral solution plus Subcutaneous Pertuzumab/Trastuzumab

Unknown · small molecule · Breast Cancers

Paclitaxel oral solution plus Subcutaneous Pertuzumab/Trastuzumab for Breast Cancers is a Unknown program (small_molecule) at Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University with 1 ClinicalTrials.gov record(s).

Internal code SYSKY-2025-397-01

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase
Unknown
Modality
small_molecule
Indication
Breast Cancers
Status
active
Trials
1